Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Queensland Health
Moodys
McKesson
AstraZeneca
Colorcon
Medtronic
Baxter

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012250

« Back to Dashboard

NDA 012250 describes CARBOCAINE, which is a drug marketed by Eastman Kodak and Hospira and is included in two NDAs. It is available from one supplier. Additional details are available on the CARBOCAINE profile page.

The generic ingredient in CARBOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 012250
Tradename:CARBOCAINE
Applicant:Hospira
Ingredient:mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 012250
Ingredient-typeAmides
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for 012250
Suppliers and Packaging for NDA: 012250
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARBOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 012250 NDA Hospira, Inc. 0409-1036 N 0409-1036-30
CARBOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 012250 NDA Hospira, Inc. 0409-1038 N 0409-1038-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1%
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2%
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 005

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1.5%
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Daiichi Sankyo
Harvard Business School
Express Scripts
US Department of Justice
Johnson and Johnson
US Army
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.